Conmed (NYSE:CNMD) shares were down this morning on second-quarter results that topped the consensus forecast. The (LOCATION)-based company posted losses of $168.3 million, or $5.65 per share, on sales of $277.2 million for the three months ended June 30, 2022, for a massive bottom-line slide deep into the red on sales growth of 8.6%. Adjusted […]